Journal article
An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.
Authors
Ung Y; Gu C; Cline K; Sun A; MacRae RM; Wright JR; Yu E; Ehrlich L; Gulenchyn KY; Shulman H
Journal
Journal of Clinical Oncology, Vol. 29, No. 15_suppl, pp. 7018–7018
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.7018
ISSN
0732-183X
